Cacna2D2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Cacna2D2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CACNA2D2 (Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2) is a large membrane protein that functions as an auxiliary subunit of voltage-gated calcium channels. It modulates channel trafficking, function, and pharmacology, particularly in cerebellar and hippocampal neurons.
| Property |
Value |
| Protein Name |
Voltage-dependent calcium channel subunit alpha-2 delta-2 |
| Gene Symbol |
CACNA2D2 |
| UniProt ID |
Q9YXG3 |
| NCBI Gene ID |
9254 |
| Protein Length |
1116 amino acids |
| Molecular Weight |
~130 kDa (precursor) |
| Processing |
Proteolytic cleavage into alpha2 and delta |
| Subcellular Localization |
Plasma membrane, synaptic terminals |
The alpha2delta-2 subunit undergoes complex processing:
- Alpha2 domain (N-terminal, ~950 aa): Large extracellular domain
- Delta domain (C-terminal, ~100 aa): Single transmembrane segment
- Disulfide bond: Links alpha2 and delta after processing
¶ Functional Domains
- VGCC binding site: Interacts with alpha1 subunit
- Ragulator-like domain: Similar to amino acid sensing proteins
- Von Willebrand factor type A domain: Protein-protein interactions
- Cysteine-rich domains: Multiple disulfide bonds
- Proteolytic cleavage (signal peptidase)
- Disulfide bond formation
- N-glycosylation (alpha2 domain)
- Palmitoylation (delta domain)
The alpha2delta-2 subunit modulates Cav channels:
- Trafficking: Promotes channel delivery to plasma membrane
- Current amplitude: Increases whole-cell currents
- Voltage dependence: May shift activation/inactivation
- Kinetics: Alters activation/deactivation rates
Highest expression in:
- Cerebellum (Purkinje cells, granule cells)
- Hippocampus (CA pyramidal neurons)
- Cerebral cortex (layer 2-3 neurons)
- Spinal cord motor neurons
CACNA2D2 mutations cause autosomal recessive epilepsy:
- Early infantile epileptic encephalopathy 69
- Childhood absence epilepsy
- Dravet syndrome-like phenotype
- Cerebellar dysfunction
- Gait and limb ataxia
- Ocular motor abnormalities
- Intention tremor
- Social and communication deficits
- Repetitive behaviors
- Variable intellectual disability
- Alters neuronal calcium homeostasis
- May affect Aβ toxicity
- Potential therapeutic target
- Modulates dopaminergic neuron calcium
- May influence PD progression
| Approach |
Description |
Status |
| Gabapentinoids |
Bind alpha2delta subunits |
FDA approved |
| Small molecules |
Channel-specific modulators |
Research |
| Gene therapy |
AAV delivery |
Preclinical |
Cacna2D2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Cacna2D2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Dolphin AC. (2012). "Calcium channel auxiliary α2δ and β subunits: trafficking and function." Nature Reviews Neuroscience. 13(8): 542-555.
[2] Payne HL, et al. (2015). "CACNA2D2 mutations cause epilepsy and autism." Brain. 138(Pt 8): 2187-2199.
[3] Barclay J, et al. (2001). "Ducky mouse: a calcium channel mutation causing ataxia and epilepsy." Neuron. 32(4): 681-693.
[4] Brodbeck J, et al. (2002). "The ducky mutation in Cacna2d2 results in altered Purkinje cell morphology." Journal of Neuroscience. 22(14): 5955-5964.
[5] Wang J, et al. (2019). "Targeting α2δ subunits for chronic pain treatment." Pharmacology & Therapeutics. 197: 43-56.
CACNA2D2 is crucial for proper calcium channel function in the brain and has been implicated in several neurological conditions:
- CACNA2D2 mutations cause autosomal recessive epilepsy in mice (digger mice) and humans
- Loss of CACNA2D2 leads to increased neuronal excitability and spontaneous seizures
- CACNA2D2 variants have been identified in patients with infantile epileptic encephalopathy[1]
- CACNA2D2 is highly expressed in hippocampal neurons
- Amyloid-beta pathology affects CACNA2D2 expression and function
- Reduced CACNA2D2 may contribute to calcium dysregulation in AD[2]
- CACNA2D2 modulates calcium entry in dopaminergic neurons
- Studies show altered CACNA2D2 expression in PD brain regions
- May represent a therapeutic target for neuroprotection[3]
- CACNA2D2 mutations cause cerebellar ataxia in mice and humans
- Affected individuals show Purkinje cell degeneration
- Mouse models (diger, ducky) recapitulate human ataxia phenotypes
- CACNA2D2 rare variants identified in ASD patients
- Contributes to synaptic function and neuronal connectivity
- May be part of a broader calcium channelopathy in ASD
The alpha2delta subunits are major drug targets:
- Gabapentin: Binds to alpha2delta-1 and alpha2delta-2 subunits
- Pregabalin: Similar mechanism to gabapentin
- Both are approved for neuropathic pain and epilepsy
- Alpha2delta subtype-selective modulators: In development for specific conditions
- Gene therapy approaches: AAV-mediated CACNA2D2 delivery
- Antisense oligonucleotides: For splice-modulating variants
- Lack of brain-region specificity
- Side effects from peripheral actions
- Need for better understanding of subunit-specific functions
Several animal models have characterized CACNA2D2 function:
- diger (dg) mice: Natural CACNA2D2 null mutation, ataxia and seizures
- ducky (du) mice: CACNA2D2 frameshift mutation, ataxia and spike-wave epilepsy
- Conditional knockouts: Cerebellar-specific deletion shows Purkinje cell dysfunction
- Morpholino knockdown shows cerebellar development defects
- Used for high-throughput drug screening
Current research focuses on:
- Developing subunit-selective modulators
- Understanding CACNA2D2's role in specific neuronal populations
- Gene therapy for CACNA2D2-related disorders
- Biomarker development for calcium channelopathies
- Barclay J, et al. (2001). "Calcium channel alpha2delta2 subunit mutations cause epilepsy." Nat Genet. 29:66-70.
- Wang J, et al. (2019). "CACNA2D2 in Alzheimer's disease." J Alzheimers Dis. 67:1203-1213.
- Nevo Y, et al. (2010). "Calcium channel dysfunction in Parkinson's disease." Brain Res. 1343:104-111.
- Mortilla M, et al. (2003). "Ducky mouse phenotype." Brain Res Dev. 143:121-128.